A 5mg semaglutide vial reconstituted with 2 mL of bacteriostatic water yields a 2.5 mg/mL solution — the ratio community reconstitution sheets cite most often because it maps the documented 0.25 mg through 2.4 mg titration range cleanly onto a U-100 insulin syringe. Larger research-format vials (10mg, 15mg) appear in community sources with proportionally larger water volumes to preserve the same concentration.
Research-context information only. Semaglutide is the active ingredient in FDA-approved products for type 2 diabetes and chronic weight management; research-peptide and compounded forms are not FDA-approved and are sold for research purposes only. Protocols, doses, and reactions reported below come from clinical trials and self-reported community sources. This article reports what has been documented, not what should be done. Consult a licensed physician for personal medical decisions.
The article below reports the dose math, the documented storage window, and the handling failures community sources flag most consistently.
How much bacteriostatic water for semaglutide
Research-format semaglutide is sold in lyophilized vials. Vial sizes cited across community vendor sheets and reconstitution references include 5mg, 10mg, and 15mg formats. The reconstitution ratio determines the final concentration in mg/mL, which in turn determines how many U-100 syringe units correspond to each titration step.
The table below reports the concentrations community sources most commonly cite for each documented vial size.
| Vial size | Bacteriostatic water added | Final concentration | Notes from community sources |
|---|---|---|---|
| 5 mg | 2 mL | 2.5 mg/mL | Most-cited ratio; clean U-100 mapping for the full 0.25 mg through 2.4 mg titration range |
| 5 mg | 1 mL | 5 mg/mL | Smaller injection volume; half the unit counts at every step |
| 10 mg | 4 mL | 2.5 mg/mL | Mirrors the 5mg-plus-2-mL ratio; same unit-to-dose mapping |
| 10 mg | 2 mL | 5 mg/mL | Higher concentration; injection volumes halve |
| 15 mg | 6 mL | 2.5 mg/mL | Same 2.5 mg/mL standard; some vendor sheets cite 3 mL for a 5 mg/mL ratio instead |
At 2.5 mg/mL on a U-100 insulin syringe, each 10-unit mark corresponds to 0.25 mg. Community sources cite this as the reason 2.5 mg/mL is the dominant reconstitution target — the documented titration steps (0.25 mg / 0.5 mg / 1 mg / 1.7 mg / 2.4 mg) fall on 10-unit, 20-unit, 40-unit, 68-unit, and 96-unit marks respectively, all within a single 100-unit syringe.
Step-by-step reconstitution as documented in community sources
The sequence below reports the steps community reconstitution sheets and vendor instruction inserts most commonly describe. It is not an instruction set.
- Surface preparation. Both vial tops — semaglutide and bacteriostatic water — are wiped with separate alcohol swabs and allowed to air-dry. Community sources commonly cite 10 to 30 seconds of dry time.
- Bacteriostatic water draw. A fresh U-100 insulin syringe is used to draw the documented water volume (2 mL for a 5mg vial at the 2.5 mg/mL target). Trial protocols describe drawing the full volume in a single pull when possible to minimize repeated puncture.
- Water injection at the vial wall. The needle is inserted into the semaglutide vial at an angle aimed at the glass wall — not directly at the lyophilized powder. Community sources cite the side-wall approach as the standard practice for protecting peptide integrity.
- Gentle dissolution. The vial is swirled with a slow rotating motion rather than shaken. Trial documentation and community references uniformly cite gentle swirling. Reconstitution typically completes within 1 to 2 minutes into a clear, colorless solution.
- Refrigerated storage. The reconstituted vial is moved to refrigeration at 2 to 8 degrees Celsius. Community sources cite the move immediately after reconstitution rather than leaving the vial at room temperature.
The full sequence is documented across vendor instruction inserts and community reconstitution sheets in close to identical form. Variations appear in water volume (1 mL, 2 mL, 2.5 mL for a 5mg vial) rather than in technique.
Storage after reconstitution
USP guidance describes a 28-day multi-dose window for bacteriostatic water under aseptic technique. Community sources commonly cite the same 28-day window for reconstituted semaglutide held continuously refrigerated at 2 to 8 degrees Celsius.
The conditions community reconstitution sheets cite as the documented storage protocol:
- Temperature: 2 to 8 degrees Celsius (refrigerator, not freezer)
- Light: protected from direct light; vials kept in the original carton or opaque container
- Movement: minimal disturbance; vials not stored in the refrigerator door where temperature cycling is greatest
- Aseptic technique: alcohol swab on the stopper before every puncture; fresh insulin syringe per draw
Self-reported community timelines describe degradation signals — cloudiness, particulate formation, loss of clear-colorless appearance — appearing earlier under non-ideal storage. Room-temperature storage, freeze-thaw cycling, and repeated stopper puncture without alcohol swab are the three handling failures most frequently cited in community degradation reports.
Common mistakes community sources cite
Several handling failures appear repeatedly in community reconstitution reports and vendor support threads. The list below reports what community sources describe, not instruction.
- Shaking the vial instead of swirling. Community sources commonly cite aggressive shaking as a denaturation trigger. The peptide is a long chain of amino acids; mechanical force can disrupt tertiary structure.
- Injecting water directly onto the lyophilized powder. The pressure of a direct-stream injection has been cited as a mechanical-damage source. Community sheets describe aiming the water stream at the glass wall instead.
- Using non-USP bacteriostatic water. Community sources commonly cite cloudy-vial outcomes traced to bacteriostatic water sourced from marketplace listings that lack USP labeling, lot tracking, or 0.9% benzyl alcohol confirmation. The cheapest insurance is buying USP-grade product from a vendor that can confirm the chain of custody.
- Storing at room temperature. Trial documentation describes semaglutide degradation accelerating at temperatures above the documented 2 to 8 degrees Celsius range. Community degradation reports cluster around room-temperature storage as the most common contributing factor.
- Freeze-thaw cycling. Frozen and re-thawed peptide solutions are repeatedly cited in community sources as producing visible cloudiness on rewarming. The 2 to 8 degrees Celsius range — not below — is the documented target.
- Re-using insulin syringes across draws. A single-use syringe per draw is the documented practice cited in community sources. Repeated use of the same syringe introduces a contamination pathway that compounds with each draw.
The cumulative pattern is that documented protocols are conservative across temperature, technique, and aseptic handling — and community reports of failed reconstitutions cluster around departures from that conservative baseline.
Bottom line
The most-cited reconstitution ratio for research-format semaglutide is 2 mL of bacteriostatic water per 5mg vial, producing a 2.5 mg/mL concentration that maps the documented titration range cleanly onto a U-100 insulin syringe. Larger vials (10mg, 15mg) appear in community sources with proportionally larger water volumes to preserve the same concentration. Storage is documented at 2 to 8 degrees Celsius across the 28-day multi-dose window described by USP guidance.
Related reading
- What Is Bacteriostatic Water? Benzyl Alcohol + Uses (2026) — Composition, benzyl alcohol mechanism, and USP-grade specifications.
- Bacteriostatic Water vs Sterile Water: Which to Use (2026) — Why the 0.9% benzyl alcohol changes the entire multi-dose window.
- How Long Does Bacteriostatic Water Last? 28-Day Rule (2026) — What the USP guidance actually says and where community sources track it.
- Bacteriostatic Water for Tirzepatide: How Much + How Long (2026) — Sibling GLP-1 reconstitution math for 10mg, 30mg, and 60mg research vials.
- Bacteriostatic Water for Retatrutide: Reconstitution Math (2026) — Triple-agonist vial sizes and the math community sources cite.
